Kesediaan Vaksinasi dan Kesediaan Bayar Vaksinasi Booster Covid 19 : Literature Review
Willingness to Vacinate dan Willingness to Pay Vaksinasi Booster Covid19 : Literature Review
Abstract
Latar Belakang : Capaian vaksinasi booster masih belum mencapai cakupan yang optimal. Cakupan vaksinasi booster (dosis 3) di Indonesia masih terbilang cukup rendah yaitu sekitar 29.83%. Pelaksanaan program vaksinasi booster memberikan banyak tantangan. Di antaranya yang sangat penting menyangkut pertanyaan apakah masyarakat mau menerima dan mau membeli vaksin tersebut apabila diperlukan.
Tujuan : Penelitian ini bertujuan untuk mengidentifikasi faktor penting yang mempengaruhi kesediaan masyarakat untuk menerima dan membayar vaksinasi booster Covid19.
Metode: Tinjauan sistematik menggunakan panduan PRISMA (Preferred Reporting Items for Systematic Review or Meta-Analysis). Pencarian data menggunakan search engine yaitu Pubmed, ScienceDirect, Embase dan Scopus mulai tahun 2021 sampai dengan tahun 2022. Penulis menggunakan kriteria inklusi dan eksklusi untuk mengidentifikasi studi yang akan direviu. Ditemukan 22 studi yang memenuhi kriteria inklusi.
Hasil: Sebagian besar studi menunjukkan hasil bahwa responden bersedia untuk menerima vaksinasi booster (> 60%) dan satu studi yang menunjukkan hasil yang rendah yaitu < 50%. Beberapa studi menunjukkan kesediaan responden untuk membayar vaksinasi booster, yaitu <RM50, Mean 109 – 189 CNY, 0-300 CNY, dan <100 - ≥500 CNY. Kesediaan untuk menerima dan membayar vaksinasi booster dipengaruhi oleh faktor sosio-demografi, faktor persepsi individu dan faktor eksternal berupa kebijakan dari pemerintah maupun saran dari tenaga kesehatan.
Kesimpulan: Temuan studi dapat memberikan informasi bagi pembuat kebijakan untuk merancang program vaksinasi dan skema keuangan yang lebih baik di masa depan. Dukungan keuangan tetap diperlukan untuk sebagian masyarakat yang kurang mampu dari sisi ekonomi.
References
Cerda AA, GarcÃa LY. Willingness to Pay for a COVID-19 Vaccine. Appl Health Econ Health Policy [Internet]. 2021;19(3):343–51. Available from: https://doi.org/10.1007/s40258-021-00644-6
Nieuwlaat R, Mbuagbaw L, Mertz D, Burrows LL, Bowdish DME, Moja L, et al. Coronavirus Disease 2019 and Antimicrobial Resistance: Parallel and Interacting Health Emergencies. Clin Infect Dis. 2021;72(9):1657–9.
Deng SQ, Peng HJ. Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China. J Clin Med. 2020;9(2).
Lurie N. Developing Covid-19 Vaccines at Pandemic Speed. N Engl J Med [Internet]. 2020;108(1):1969–73. Available from: nejm.org
Fan Y-J, Chan K-H, Hung IF. Safety and Efficacy of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Different Vaccines at Phase 3. Vol. 9, Vaccines. 2021.
Feikin DR, Higdon MM, Abu-Raddad LJ, Andrews N, Araos R, Goldberg Y, et al. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression. Lancet [Internet]. 2022;399(10328):924–44. Available from: http://dx.doi.org/10.1016/S0140-6736(22)00152-0
Ewen Callaway. COVID vaccine boosters: the most important questions. Nature [Internet]. 2021; Available from: https://www.nature.com/articles/d41586-021-02158-6
Hou Z, Jie Chang, Yue D, Fang H, Meng Q, Zhang Y. Determinants of willingness to pay for self-paid vaccines in China. Vaccine [Internet]. 2014;32(35):4471–7. Available from: https://www.sciencedirect.com/science/article/pii/S0264410X14008482
Harapan H, Fajar JK, Sasmono RT, Kuch U. Dengue vaccine acceptance and willingness to pay. Hum Vaccines Immunother [Internet]. 2017;13(4):786–90. Available from: http://dx.doi.org/10.1080/21645515.2016.1259045
Ughasoro MD, Esangbedo DO, Tagbo BN, Mejeha IC. Acceptability and willingness-to-pay for a hypothetical ebola virus vaccine in Nigeria. PLoS Negl Trop Dis. 2015;9(6):1–15.
Szilagyi PG, Thomas K, Shah MD, Vizueta N, Cui Y, Vangala S, et al. National Trends in the US Public’s Likelihood of Getting a COVID-19 Vaccine - April 1 to December 8, 2020. JAMA - J Am Med Assoc. 2021;325(4):396–8.
Kementerian Kesehatan Republik Indonesia. Vaksinasi COVID-19 Nasional [Internet]. Status Vaksin. 2023 [cited 2023 Jan 26]. Available from: https://vaksin.kemkes.go.id/#/vaccines
Hynes S, Armstrong CW, Xuan BB, Ankamah-Yeboah I, Simpson K, Tinch R, et al. Have environmental preferences and willingness to pay remained stable before and during the global Covid-19 shock? Ecol Econ J Int Soc Ecol Econ. 2021 Nov;189:107142.
Rodrigues CMC, Plotkin SA. Impact of Vaccines; Health, Economic and Social Perspectives. Front Microbiol. 2020;11.
Bartsch SM, Wedlock PT, O’Shea KJ, Cox SN, Strych U, Nuzzo JB, et al. Lives and Costs Saved by Expanding and Expediting Coronavirus Disease 2019 Vaccination. J Infect Dis. 2021;224(6):938–48.
Kohli M, Maschio M, Becker D, Weinstein MC. The potential public health and economic value of a hypothetical COVID-19 vaccine in the United States: Use of cost-effectiveness modeling to inform vaccination prioritization. Vaccine [Internet]. 2021;39(7):1157–64. Available from: https://doi.org/10.1016/j.vaccine.2020.12.078
Wu F, Yuan Y, Deng Z, Yin D, Shen Q, Zeng J, et al. Acceptance of COVIDâ€19 booster vaccination based on the protection motivation theory: A crossâ€sectional study in China. J Med Virol [Internet]. 2022 Sep 9;94(9):4115–24. Available from: https://onlinelibrary.wiley.com/doi/10.1002/jmv.27825
Achrekar GC, Batra K, Urankar Y, Batra R, Iqbal N, Choudhury SA, et al. Assessing COVID-19 Booster Hesitancy and Its Correlates: An Early Evidence from India. Vaccines [Internet]. 2022 Jun 30;10(7):1048. Available from: https://www.mdpi.com/2076-393X/10/7/1048
Galanis P, Vraka I, Katsiroumpa A, Siskou O, Konstantakopoulou O, Katsoulas T, et al. Predictors of Willingness of the General Public to Receive a Second COVID-19 Booster Dose or a New COVID-19 Vaccine: A Cross-Sectional Study in Greece. Vaccines [Internet]. 2022 Jun 30;10(7):1061. Available from: https://www.mdpi.com/2076-393X/10/7/1061
Tan KYK, Soh ASE, Ong BWL, Chen MIC, Griva K. Determining the Prevalence and Correlates of COVID-19 Booster Vaccine Hesitancy in the Singapore Population Following the Completion of the Primary Vaccination Series. Vaccines. 2022;10(7).
Abouzid M, Ahmed AA, El-Sherif DM, Alonazi WB, Eatmann AI, Alshehri MM, et al. Attitudes toward Receiving COVID-19 Booster Dose in the Middle East and North Africa (MENA) Region: A Cross-Sectional Study of 3041 Fully Vaccinated Participants. Vaccines [Internet]. 2022 Aug 6;10(8):1270. Available from: https://www.mdpi.com/2076-393X/10/8/1270
Lin Y, Huang Z, Xu X, Du W, Alias H, Hu Z, et al. Multi-dimensional psychosocial factors influencing the willingness to receive a COVID-19 vaccine booster: A survey among the public in Mainland China. Hum Vaccin Immunother [Internet]. 2022 Nov 30;18(6):2126667. Available from: https://www.tandfonline.com/doi/full/10.1080/21645515.2022.2126667
Rzymski P, Poniedziałek B, Fal A. Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland. Vaccines [Internet]. 2021 Nov 5;9(11):1286. Available from: https://www.mdpi.com/2076-393X/9/11/1286
Aw J, Jie J, Seng B, Si S, Seah Y, Low LL. COVID-19 Vaccine Hesitancy — A Scoping Review of Literature in High-Income Countries. 2021;2019(December 2019).
Mueangpoon K, Inchan C, Kaewmuneechoke P, Rattana P, Budsratid S, Japakiya S, et al. Self-Reported COVID-19 Vaccine Hesitancy and Willingness to Pay: A Cross-Sectional Survey in Thailand. Vaccines [Internet]. 2022 Apr 16;10(4):627. Available from: https://www.mdpi.com/2076-393X/10/4/627
Acharya D, Budhathoki CB, Khanal SP. Factors associated to acceptance and willingness to pay for COVID vaccine in Nepal. J Prev Med Hyg [Internet]. 2022 Jun;63(2):E240–56. Available from: http://www.ncbi.nlm.nih.gov/pubmed/35968064
Zhang Y, Luo X, Ma ZF. Willingness of the general population to accept and pay for COVID-19 vaccination during the early stages of COVID-19 pandemic: a nationally representative survey in mainland China. Hum Vaccin Immunother [Internet]. 2021 Jun 3;17(6):1622–7. Available from: https://www.tandfonline.com/doi/full/10.1080/21645515.2020.1847585
Wake AD. The willingness to receive covid-19 vaccine and its associated factors: “vaccination refusal could prolong the war of this pandemic†– a systematic review. Risk Manag Healthc Policy. 2021;14(March):2609–23.
Wang J, Lyu Y, Zhang H, Jing R, Lai X, Feng H, et al. Willingness to pay and financing preferences for COVID-19 vaccination in China. Vaccine [Internet]. 2021;39(14):1968–76. Available from: https://doi.org/10.1016/j.vaccine.2021.02.060
Lai X, Zhu H, Wang J, Huang Y, Jing R, Lyu Y, et al. Public Perceptions and Acceptance of COVID-19 Booster Vaccination in China: A Cross-Sectional Study. Vaccines [Internet]. 2021 Dec 10;9(12):1461. Available from: https://www.mdpi.com/2076-393X/9/12/1461
Chang CT, Lim X-J, Chew C-C, Rajan P, Chan H-K, Abu Hassan MR, et al. Preferences and willingness of accepting COVID-19 vaccine booster: Results from a middle-income country. Vaccine [Internet]. 2022 Dec;40(52):7515–9. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0264410X22013342
Zhou HJ, Pan L, Shi H, Luo JW, Wang P, Porter HK, et al. Willingness to pay for and willingness to vaccinate with the COVID-19 vaccine booster dose in China. Front Pharmacol [Internet]. 2022 Sep 20;13:1013485. Available from: https://www.frontiersin.org/articles/10.3389/fphar.2022.1013485/full
Tung T-H, Lin X-Q, Chen Y, Zhang M-X, Zhu J-S. Willingness-to-pay for a booster dose of inactivated SARS-CoV-2 vaccine in Taizhou, China. Hum Vaccin Immunother [Internet]. 2022 Jul 26;2099210. Available from: https://www.tandfonline.com/doi/full/10.1080/21645515.2022.2099210
Wong LP, Alias H, Wong PF, Lee HY, AbuBakar S. The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay. Hum Vaccines Immunother [Internet]. 2020;16(9):2204–14. Available from: https://doi.org/10.1080/21645515.2020.1790279
Harapan H, Wagner AL, Yufika A, Winardi W, Anwar S, Gan AK, et al. Willingness-to-pay for a COVID-19 vaccine and its associated determinants in Indonesia. Hum Vaccines Immunother [Internet]. 2020;16(12):3074–80. Available from: https://doi.org/10.1080/21645515.2020.1819741
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-Non Commercial License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
The content of this website is licensed under a Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) license. 
